Researchers from the University of Bern analyzed over 300,000 FDA reports and found semaglutide use was linked to a higher ...

Oral semaglutide cuts major heart risks in people with type 2 diabetes by 14%, offering a powerful pill-based option. Both ...

Ophthalmology Times - ophthalmology news, articles, and events in a timely and accurate manner for members of the ophthalmic ...

Munich news, health insurance, technology, jobs and other topics for expatriates. The Eye Newspapers covers daily news and offers services for foreigners.

For patients with diabetes, semaglutide use is associated with an increased risk for nonarteritic anterior ischemic optic ...

Trial confirms that oral semaglutide lowers cardiovascular risk in type 2 diabetes, regardless of SGLT2i use. Read more!

Eye health: If you have a history ... This is because semaglutide, the active ingredient in Ozempic may increase your risk of kidney injury. How long does it take Ozempic to get out of your ...

The researchers tracked nearly 175,000 patients with diabetes who received semaglutide ... The higher risk of developing the sight-threatening eye problem known as nonarteritic anterior ischemic ...

Compounded semaglutide and Ozempic are different products. While both may be used in people with type 2 diabetes, Ozempic is approved by the FDA, but compounded semaglutide is not. Compounded ...

Semaglutide use associated with increased risk for NAION at the two-, three-, and four-year time point from the index date.